Stassi G - Search Results

1

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.

Gaggianesi M, Di Franco S, Pantina VD, Porcelli G, D'Accardo C, Verona F, Veschi V, Colarossi L, Faldetta N, Pistone G, Bongiorno MR, Todaro M, Stassi G. Gaggianesi M, et al. Among authors: stassi g. Front Oncol. 2021 Jul 20;11:702642. doi: 10.3389/fonc.2021.702642. eCollection 2021. Front Oncol. 2021. PMID: 34354950 Free PMC article. Review.

2

T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.

Candore G, Cigna D, Todaro M, De Maria R, Stassi G, Giordano C, Caruso C. Candore G, et al. Among authors: stassi g. Hum Immunol. 1995 Apr;42(4):289-94. doi: 10.1016/0198-8859(94)00103-w. Hum Immunol. 1995. PMID: 7558912

3

Defective T cell receptor/CD3 complex signaling in human type I diabetes.

De Maria R, Todaro M, Stassi G, Di Blasi F, Giordano M, Galluzzo A, Giordano C. De Maria R, et al. Among authors: stassi g. Eur J Immunol. 1994 Apr;24(4):999-1002. doi: 10.1002/eji.1830240433. Eur J Immunol. 1994. PMID: 8149968

4

Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.

Giordano C, De Maria R, Stassi G, Todaro M, Richiusa P, Giordano M, Testi R, Galluzzo A. Giordano C, et al. Among authors: stassi g. Diabetologia. 1995 Dec;38(12):1449-54. doi: 10.1007/BF00400606. Diabetologia. 1995. PMID: 8786019

5

Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.

Stassi G, Todaro M, De Maria R, Candore G, Cigna D, Caruso C, Galluzzo A, Giordano C. Stassi G, et al. Hum Immunol. 1997 Jun;55(1):39-45. doi: 10.1016/s0198-8859(97)00072-4. Hum Immunol. 1997. PMID: 9328788

6

Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.

Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, Testi R, De Maria R. Stassi G, et al. J Immunol. 1999 Jan 1;162(1):263-7. J Immunol. 1999. PMID: 9886394

7

Defective apoptosis as potential mechanism in the tumorogenesis of myelolipoma.

Cappello F, Farina F, Di Felice V, Marcianò V, Todaro M, Balsano G, Zummo G, Stassi G. Cappello F, et al. Among authors: stassi g. Eur J Histochem. 1999;43(1):15-8. Eur J Histochem. 1999. PMID: 10340139

8

Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.

Stassi G, Di Felice V, Todaro M, Cappello F, Zummo G, Farina F, Trucco M, De Maria R. Stassi G, et al. Arch Immunol Ther Exp (Warsz). 1999;47(3):129-33. Arch Immunol Ther Exp (Warsz). 1999. PMID: 10470438 Review.

9

Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease.

Farina F, Cappello F, Todaro M, Bucchieri F, Peri G, Zummo G, Stassi G. Farina F, et al. Among authors: stassi g. J Histochem Cytochem. 2000 Jan;48(1):57-62. doi: 10.1177/002215540004800106. J Histochem Cytochem. 2000. PMID: 10653586 Free article.

10

Fas-FasL in Hashimoto's thyroiditis.

Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R. Stassi G, et al. J Clin Immunol. 2001 Jan;21(1):19-23. doi: 10.1023/a:1006732713634. J Clin Immunol. 2001. PMID: 11321234 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters